PENG vs Femoral Block for Hip Fracture Analgesia

Part of paid clinical trials in Manhattan, New York.

Sponsor
Weill Medical College of Cornell University
Study ID
NCT07073209
Status
Recruiting
Apply to this trial

Conditions

  • Hip Fractures

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • PENG Block Administration — PROCEDURE
    Policy for the PENG block administration: 30 mL of Bupivacaine 0.25% 1:200,000 epinephrine Dexamethasone 4 mg% While these drugs are administered to participants, the intervention under evaluation is the PENG Block anesthesia technique.
  • Femoral Block Administration — PROCEDURE
    Policy for the Femoral block administration: 30 mL of Bupivacaine 0.25% 1:200,000 epinephrine Dexamethasone 4 mg While these drugs are administered to participants, the intervention under evaluation is the Femoral Block anesthesia technique.
  • Bupivacaine , epinephrine Dexamethasone — DRUG
    30 mL of Bupivacaine 0.25% 1:200,000 epinephrine Dexamethasone 4 mg%

Study Details

This study aims to compare the Pericapsular Nerve Group (PENG) block with femoral block for hip fracture pain. Participants presenting to the hospital with a diagnosis of hip fracture and consenting to analgesic block will receive either a PENG or femoral block. The choice of block will be dictated by a randomized monthly schedule, and all participants presenting during each four-week period will receive the designated block. A sub-group analysis will be performed to determine any difference in efficacy in participants with intracapsular versus extracapsular fractures.

Key Dates

Start date
Jul 10, 2025
Status verified
May 2026
Primary completion
Mar 31, 2027
Completion
Apr 30, 2027

Study Design

Enrollment
352 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Experimental: PENG Block Administration
    Policy for the administration of the PENG block as per clinical guidelines to all subjects presenting to the hospital with a diagnosis of hip fracture and consenting to analgesic block
  • Experimental: Femoral Block Administration
    Policy for the administration of the Femoral block as per clinical guidelines to all subjects presenting to the hospital with a diagnosis of hip fracture and consenting to analgesic block

Primary Outcome Measure

Mean Change in Numerical Rating Scale (NRS) Pain Score One Hour Post Block for all Subjects [ Time Frame: Baseline, 1-hour post block ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Weill Cornell MedicineManhattanNew York10065
Tiffany Tedore, M.D.
[email protected]
(212) 746-2725
Michele Steinkamp, R.N.
[email protected]
+1 212 746 2953

Find similar trials in Manhattan, NY

By research site
Weill Cornell Medicine· Manhattan, NY

Related Studies